Moderna
MRNA
#1208
Rank
NZ$33.07 B
Marketcap
NZ$84.64
Share price
0.46%
Change (1 day)
43.60%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$33.07 Billion

As of February 2026 Moderna has a market cap of NZ$33.07 Billion. This makes Moderna the world's 1208th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$33.07 B57.12%
2025NZ$21.04 B-23.13%
2024NZ$27.38 B-54.33%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.91%
2021NZ$150.76 B163.14%
2020NZ$57.29 B486.18%
2019NZ$9.77 B30.58%
2018NZ$7.48 B

End of Day market cap according to different sources

On Feb 23rd, 2026 the market cap of Moderna was reported to be:

NZ$32.91 Billion
by Nasdaq info icon info icon
NZ$32.92 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$994.40 B 2,906.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$541.14 B 1,536.27%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$518.62 B 1,468.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
NZ$0.94 B-97.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$4.98 B-84.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
NZ$1.39 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$73.95 B 123.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
NZ$14.93 B-54.83%๐Ÿ‡บ๐Ÿ‡ธ USA